PB
Patrick Burnett (See Remarks) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $395K of ARQT (15,000 sh across 2 lots, as filed), executed Aug 11. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.1M
shares × price, as filed
Last traded
Aug 12
Filed Aug 13
Median ADV $51.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
ARQTRecent filings
ARQTSALE
Arcutis Biotherapeutics, Inc.
View filing →
$162K16,023 sh × $10.14
Exec Nov 22 2024
Filed Nov 26 2024 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $711K
69,126 sh across 2 lots
Exec Nov 14 2024
Filed Nov 18 2024 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $134K
15,441 sh × $8.68
Exec Nov 4 2024
Filed Nov 5 2024 · 5:30 PM ET